ASCENDIS PHARMA A/S - ADR (ASND) Stock Earnings Estimates

USA • Nasdaq • NASDAQ:ASND • US04351P1012

224.67 USD
+1.08 (+0.48%)
At close: Feb 3, 2026
224.67 USD
0 (0%)
After Hours: 2/3/2026, 5:55:46 PM

Full estimates are only available for subscribed users, you can see which data is available below.

Subscribed users also see more surprise data, now it is restricted to 4 quarters.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033
Revenue
YoY % growth
ASND revenue by date.ASND revenue by date.
51.17M
557.71%
266.718M
421.24%
363.641M
36.34%
725.08M
99.39%
1.335B
84.12%
1.919B
43.75%
2.583B
34.60%
3.043B
17.81%
3.394B
11.53%
3.596B
5.95%
3.893B
8.26%
4.145B
6.47%
EBITDA
YoY % growth
ASND ebitda by date.ASND ebitda by date.
-543.86M
-24.63%
-428.796M
21.16%
-261.049M
39.12%
-116.986M
55.19%
387.37M
431.12%
824.96M
112.96%
N/AN/AN/AN/AN/AN/A
EBIT
YoY % growth
ASND ebit by date.ASND ebit by date.
-561.81M
-24.35%
-447.707M
20.31%
-278.763M
37.74%
-130.646M
53.13%
296.89M
327.25%
789.41M
165.89%
1.247B
57.97%
1.626B
30.39%
1.949B
19.86%
2.086B
7.03%
2.379B
14.05%
2.589B
8.83%
Operating Margin
ASND operating margin by date.ASND operating margin by date.
-1,097.93%-167.86%-76.66%-18.02%22.24%41.14%48.28%53.43%57.42%58.01%61.11%62.46%
EPS
YoY % growth
ASND eps by date.ASND eps by date.
-10.40
-48.36%
-8.56
17.69%
-6.57
23.25%
-3.38
48.58%
3.39
200.36%
9.07
167.39%
16.63
83.43%
21.55
29.59%
25.82
19.83%
27.20
5.33%
30.33
11.51%
33.11
9.17%

All data in EUR

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
Q4 / 25 Q1 / 26 Q2 / 26 Q3 / 26 Q4 / 26
EPS
Q2Q % growth
-0.04
93.01%
0.37
123.50%
0.42
165.66%
0.75
175.17%
1.36
3,150.81%
Revenue
Q2Q % growth
249.43M
43.42%
280.42M
177.77%
313.97M
98.66%
347.08M
62.46%
399.53M
60.18%
EBITDA
Q2Q % growth
9.991M
-44.79%
14.437M
115.67%
25.135M
157.00%
58.135M
143.56%
N/A
EBIT
Q2Q % growth
12.67M
3,208.09%
31.748M
132.83%
51.284M
196.85%
73.536M
568.69%
110.89M
775.22%

All data in EUR

Recent Earnings VS Estimates Surprises (EUR)
PeriodReportedEstimateDifferenceSurprise
Q3 2025
Q2Q % growth
-1.00
41.86%
-0.22-0.78-345.63%
Q2 2025
Q2Q % growth
-0.64
66.49%
-1.270.6349.75%
Q1 2025
Q2Q % growth
-1.58
31.30%
-1.52-0.06-3.72%
Q4 2024
Q2Q % growth
-0.64
58.44%
-0.980.3434.50%
Q3 2024
Q2Q % growth
-1.72
40.28%
-1.770.053.09%
Q2 2024
Q2Q % growth
-1.91
11.57%
-1.41-0.50-35.43%
Q1 2024
Q2Q % growth
-2.30
-16.16%
-1.53-0.77-50.09%
Q4 2023
Q2Q % growth
-1.54
58.38%
-2.070.5325.51%
Q3 2023
Q2Q % growth
-2.88
4.95%
-2.43-0.45-18.71%
Q2 2023
Q2Q % growth
-2.16
-47.95%
-2.640.4818.26%
Q1 2023
Q2Q % growth
-1.98
10.41%
-2.710.7327.04%
Q4 2022
Q2Q % growth
-3.70
-97.86%
-2.61-1.09-41.66%
Q3 2022
Q2Q % growth
-3.03
-106.12%
-2.54-0.49-19.31%
Q2 2022
Q2Q % growth
-1.46
41.60%
-2.170.7132.87%
Q1 2022
Q2Q % growth
-2.21
-88.89%
-2.04-0.17-8.34%
Q4 2021
Q2Q % growth
-1.87
29.17%
-2.390.5221.73%
Q3 2021
Q2Q % growth
-1.47
36.36%
-2.340.8737.16%
Q2 2021
Q2Q % growth
-2.50
-26.90%
-2.27-0.23-10.14%
Q1 2021
Q2Q % growth
-1.17
11.36%
-1.740.5732.73%
Q4 2020
Q2Q % growth
-2.64 -1.58-1.06-66.91%
Q3 2020
Q2Q % growth
-2.31 -1.61-0.70-43.80%
Q2 2020
Q2Q % growth
-1.97 -1.48-0.49-32.97%
Q1 2020
Q2Q % growth
-1.32 -1.380.064.01%
ASND Yearly EPS VS EstimatesASND Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 0 10 -10 20 30
Recent Revenue VS Estimates Surprises (EUR)
PeriodReportedEstimateDifferenceSurprise
Q3 2025
Q2Q % growth
213.634M
269.40%
218.08M-4.446M-2.04%
Q2 2025
Q2Q % growth
158.045M
339.04%
144.38M13.665M9.46%
Q1 2025
Q2Q % growth
100.954M
5.28%
96.537M4.417M4.58%
Q4 2024
Q2Q % growth
173.916M
26.30%
122.1M51.816M42.44%
Q3 2024
Q2Q % growth
57.833M
20.40%
84.011M-26.178M-31.16%
Q2 2024
Q2Q % growth
35.998M
-24.04%
85.651M-49.653M-57.97%
Q1 2024
Q2Q % growth
95.894M
185.49%
81.081M14.813M18.27%
Q4 2023
Q2Q % growth
137.703M
501.32%
64.385M73.318M113.87%
Q3 2023
Q2Q % growth
48.034M
214.15%
49.077M-1.043M-2.13%
Q2 2023
Q2Q % growth
47.393M
669.37%
38.097M9.296M24.40%
Q1 2023
Q2Q % growth
33.589M
391.79%
21.956M11.633M52.98%
Q4 2022
Q2Q % growth
22.9M
367.35%
20.233M2.667M13.18%
Q3 2022
Q2Q % growth
15.29M
1,277.48%
9.062M6.228M68.73%
Q2 2022
Q2Q % growth
6.16M
503.92%
5.927M233K3.93%
Q1 2022
Q2Q % growth
6.83M
810.67%
4.766M2.064M43.31%
Q4 2021
Q2Q % growth
4.9M
807.41%
2.712M2.188M80.68%
Q3 2021
Q2Q % growth
1.11M
-59.78%
1.16M-50K-4.31%
Q2 2021
Q2Q % growth
1.02M
-29.17%
862.41K157.59K18.27%
Q1 2021
Q2Q % growth
750K
-66.37%
1.917M-1.167M-60.88%
Q4 2020
Q2Q % growth
540K 1.709M-1.169M-68.40%
Q3 2020
Q2Q % growth
2.76M 1.426M1.334M93.55%
Q2 2020
Q2Q % growth
1.44M 2.23M-790K-35.43%
Q1 2020
Q2Q % growth
2.23M 1.89M340K17.99%
ASND Yearly Revenue VS EstimatesASND Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 1B 2B 3B 4B
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPS-303.57% -136.76% -4.05% -35.93%
Revenue0.53% -7.22% 0.25% -2.55%